Legal Representation
Attorney
Anthony E. Bennett
USPTO Deadlines
Next Deadline
1070 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-07-03)
Due Date
July 03, 2028
Grace Period Ends
January 03, 2029
Application History
38 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
May 6, 2025 | NA71 | E | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | Loading... |
May 6, 2025 | 71.P | O | REGISTERED - PARTIAL SEC 71 ACCEPTED | Loading... |
May 5, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
Dec 20, 2024 | ES71 | I | TEAS SECTION 71 RECEIVED | Loading... |
Jul 13, 2024 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
Jun 15, 2024 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
Nov 1, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
Oct 26, 2018 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
Oct 5, 2018 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
Oct 5, 2018 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
Oct 3, 2018 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Jul 3, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Apr 17, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 13, 2018 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
Mar 28, 2018 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
Mar 28, 2018 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Mar 28, 2018 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
Mar 10, 2018 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Mar 1, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Mar 1, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 1, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Nov 3, 2017 | CNRT | O | NON-FINAL ACTION MAILED | Loading... |
Nov 2, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Oct 23, 2017 | CNEA | O | EXAMINERS AMENDMENT MAILED | Loading... |
Oct 20, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Oct 20, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Oct 9, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 9, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Oct 9, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 24, 2017 | RFNP | P | REFUSAL PROCESSED BY IB | Loading... |
Jun 7, 2017 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Jun 7, 2017 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
May 26, 2017 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
May 25, 2017 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
May 24, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
May 22, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 22, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
May 18, 2017 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 041
Education services, namely, providing training in the form of classes and seminars in the field of immunotherapy; [ organization and conducting of educational colloquiums, educational conferences and educational conventions in the field of immunotherapy; organization and conducting of non-virtual educational forums in the field of immunotherapy; ] provision of non-downloadable videos in the field of immunotherapy online [ ; electronic desktop publishing; provision of non-downloadable online electronic publications; organization of exhibitions for educational purposes ]
Class 042
[ Scientific research services for medical purposes in the field of immunotherapy; ] research in the field of immunotherapy; scientific research in the field of processing and treatment of allergies; [ scientific research in the nature of discovery and development of allergens; ] design of methods for the treatment of allergy-causing by the combination of immune cells from the skin [ ; research and development of new products for others ]
Classification
International Classes
041
042